Skip to main content

Table 3 Treatment by time effect of DCS on BACS and EQS

From: Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study

  

Week within treatment phase

Analysis

 
 

Treatment

Baseline

Week 6

treatment x time

  

Mean

SD

Mean

SD

F

p

BACS

 VM

DCS

34.18

15.09

37.15

16.11

0.01

0.91

 

PCB

37.15

16.04

  

 DS

DCS

16.48

5.76

16.97

5.96

0.20

0.65

 

PCB

17.58

5.84

  

 TM

DCS

58.73

21.84

60.64

21.92

0.02

0.90

 

PCB

63.33

20.69

  

 SC

DCS

46.52

16.36

47.03

15.71

0.89

0.35

 

PCB

48.42

16.21

  

 VFC

DCS

15.21

4.70

16.64

6.34

4.06

0.053

 

PCB

17.24

6.44

  

 VFL

DCS

17.55

9.58

18.12

8.23

1.06

0.31

 

PCB

18.48

8.20

  

 TOL

DCS

14.73

5.57

15.70

5.62

0.13

0.72

 

PCB

16.00

4.33

  

EQS

 intra

DCS

39.29

14.40

41.04

18.23

0.08

0.78

 

PCB

38.75

15.28

  

 inter

DCS

38.18

14.54

38.25

15.77

1.53

0.23

 

PCB

38.75

15.28

  

 situa

DCS

30.79

16.89

33.46

18.66

0.00

0.99

 

PCB

32.36

17.20

  
  1. BACS Brief Assessment of Cognition in Schizophrenia, VM verbal memory, DS digit sequencing task, TM token motor task, SC symbolic coding, VFC verbal fluency of category, VFL verbal fluency of letter, TOL tower of London, EQS Emotional Intelligence Scale, intra intrapersonal domain, inter interpersonal domain, situa, situational domain; ‘Baseline’ indicates Week 0 both for the first and second phase
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us